The Food and Drug Administration is advising consumers not to purchase or use X3 500K GOLD EDITION, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
Similar Posts
October 10, 2024: Meeting of the Cardiovascular and Renal Drugs Advisory Committee – 10/10/2024
The Committee will discuss new drug application (NDA) 215244, for elamipretide hydrochloride injection, submitted by Stealth BioTherapeutics Inc., for the treatment of Barth Syndrome.HealBerry – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetPhysicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAsFDA Clinical Investigator Training Course (CITC) 2024 – 12/10/2024
FDA Clinical Investigator Training Course (CITC) 2024Treating and Preventing Head Lice
Head lice affect millions of children every year. Although head lice are a year-round problem, cases usually peak during back-to-school time. FDA-approved treatments for head lice include over-the-counter and prescription drugs.Early Alert: Large Volume Pump Primary Administration Set Reverse Flow Issue from Fresenius Kabi
Some Ivenix LVP Primary Administration Sets were assembled with the drip chamber and Luer Lock components in reversed positions, potentially leading to clinical complications